Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1963
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 8
1964 16
1965 7
1966 7
1967 14
1968 21
1969 39
1970 37
1971 45
1972 47
1973 28
1974 56
1975 34
1976 40
1977 49
1978 47
1979 57
1980 42
1981 39
1982 44
1983 58
1984 69
1985 76
1986 95
1987 116
1988 134
1989 155
1990 225
1991 274
1992 297
1993 315
1994 388
1995 314
1996 374
1997 396
1998 398
1999 364
2000 403
2001 427
2002 442
2003 506
2004 417
2005 440
2006 490
2007 512
2008 475
2009 509
2010 507
2011 549
2012 522
2013 597
2014 597
2015 689
2016 618
2017 612
2018 580
2019 628
2020 660
2021 640
2022 589
2023 575
2024 472
2025 39

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

16,979 results

Results by year

Filters applied: . Clear all
Page 1
PET/CT in Non-Hodgkin Lymphoma: An Update.
Zanoni L, Bezzi D, Nanni C, Paccagnella A, Farina A, Broccoli A, Casadei B, Zinzani PL, Fanti S. Zanoni L, et al. Semin Nucl Med. 2023 May;53(3):320-351. doi: 10.1053/j.semnuclmed.2022.11.001. Epub 2022 Dec 14. Semin Nucl Med. 2023. PMID: 36522191 Review.
Non-Hodgkin lymphomas represents a heterogeneous group of lymphoproliferative disorders characterized by different clinical courses, varying from indolent to highly aggressive. (18)F-FDG-PET/CT is the current state-of-the-art diagnostic imaging, for the staging, res
Non-Hodgkin lymphomas represents a heterogeneous group of lymphoproliferative disorders characterized by different clinical co
Non-Hodgkin lymphoma.
Shankland KR, Armitage JO, Hancock BW. Shankland KR, et al. Lancet. 2012 Sep 1;380(9844):848-57. doi: 10.1016/S0140-6736(12)60605-9. Epub 2012 Jul 25. Lancet. 2012. PMID: 22835603 Review.
Lymphomas are solid tumours of the immune system. Hodgkin's lymphoma accounts for about 10% of all lymphomas, and the remaining 90% are referred to as non-Hodgkin lymphoma. Non-Hodgkin lymphomas have a wide range of histological ap …
Lymphomas are solid tumours of the immune system. Hodgkin's lymphoma accounts for about 10% of all lymphomas, and the remainin …
Non-Hodgkin Lymphoma: Diagnosis and Treatment.
Ansell SM. Ansell SM. Mayo Clin Proc. 2015 Aug;90(8):1152-63. doi: 10.1016/j.mayocp.2015.04.025. Mayo Clin Proc. 2015. PMID: 26250731 Review.
Non-Hodgkin lymphomas are lymphoid malignant neoplasms with diverse biological and clinical behavior. ...Most patients respond well to treatment, but relapses are frequent and additional therapies including stem cell transplant are often needed. Because many subtype
Non-Hodgkin lymphomas are lymphoid malignant neoplasms with diverse biological and clinical behavior. ...Most patients respond
Non-Hodgkin lymphoma.
Bowzyk Al-Naeeb A, Ajithkumar T, Behan S, Hodson DJ. Bowzyk Al-Naeeb A, et al. BMJ. 2018 Aug 22;362:k3204. doi: 10.1136/bmj.k3204. BMJ. 2018. PMID: 30135071 Review. No abstract available.
Childhood, adolescent and young adult non-Hodgkin lymphoma: current perspectives.
Cairo MS, Beishuizen A. Cairo MS, et al. Br J Haematol. 2019 Jun;185(6):1021-1042. doi: 10.1111/bjh.15764. Epub 2019 Feb 6. Br J Haematol. 2019. PMID: 30729513 Free PMC article. Review.
The 6th International Symposium on Childhood, Adolescent and Young Adult (CAYA) Non-Hodgkin Lymphoma (NHL) was held in Rotterdam, Netherlands, 26-29 September, 2018. This summary manuscript is a perspective on the presentations from the plenary scientific ses …
The 6th International Symposium on Childhood, Adolescent and Young Adult (CAYA) Non-Hodgkin Lymphoma (NHL) was held in …
Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma.
McCarten KM, Nadel HR, Shulkin BL, Cho SY. McCarten KM, et al. Pediatr Radiol. 2019 Oct;49(11):1545-1564. doi: 10.1007/s00247-019-04529-8. Epub 2019 Oct 16. Pediatr Radiol. 2019. PMID: 31620854 Review.
Hodgkin lymphoma and non-Hodgkin lymphoma are common malignancies in children and are now highly treatable. ...Non-Hodgkin lymphoma includes more organ involvement such as renal, ovary, central nervous system and skin. ...
Hodgkin lymphoma and non-Hodgkin lymphoma are common malignancies in children and are now highly treatabl
Primary CNS Lymphoma.
Grommes C, DeAngelis LM. Grommes C, et al. J Clin Oncol. 2017 Jul 20;35(21):2410-2418. doi: 10.1200/JCO.2017.72.7602. Epub 2017 Jun 22. J Clin Oncol. 2017. PMID: 28640701 Free PMC article. Review.
Primary CNS lymphoma (PCNSL) is a rare form of extranodal non-Hodgkin lymphoma that is typically confined to the brain, eyes, and cerebrospinal fluid without evidence of systemic spread. ...
Primary CNS lymphoma (PCNSL) is a rare form of extranodal non-Hodgkin lymphoma that is typically confined to the …
Navigating the Evolving Treatment Landscape of Diffuse Large B-Cell Lymphoma.
Nastoupil LJ, Bartlett NL. Nastoupil LJ, et al. J Clin Oncol. 2023 Feb 1;41(4):903-913. doi: 10.1200/JCO.22.01848. Epub 2022 Dec 12. J Clin Oncol. 2023. PMID: 36508700 Review.
Diffuse large B-cell lymphoma, the most common subtype of non-Hodgkin lymphoma, comprises a heterogenous group of morphologically, genetically, and clinically distinct diseases. ...
Diffuse large B-cell lymphoma, the most common subtype of non-Hodgkin lymphoma, comprises a heterogenous group o …
Primary central nervous system lymphoma.
de Koning ME, Hof JJ, Jansen C, Doorduijn JK, Bromberg JEC, van der Meulen M. de Koning ME, et al. J Neurol. 2024 May;271(5):2906-2913. doi: 10.1007/s00415-023-12143-w. Epub 2023 Dec 19. J Neurol. 2024. PMID: 38112784 Review.
Primary central nervous system lymphoma (PCNSL) is a rare type of non-Hodgkin lymphoma (NHL) manifesting in the brain, spinal cord, cerebrospinal fluid and/or eyes, in the absence of systemic manifestations. ...
Primary central nervous system lymphoma (PCNSL) is a rare type of non-Hodgkin lymphoma (NHL) manifesting in the …
Non-Hodgkin Lymphoma Metabolism.
Kirsch BJ, Chang SJ, Le A. Kirsch BJ, et al. Adv Exp Med Biol. 2018;1063:95-106. doi: 10.1007/978-3-319-77736-8_7. Adv Exp Med Biol. 2018. PMID: 29946778 Review.
Non-Hodgkin lymphomas (NHLs) are a heterogeneous group of lymphoid neoplasms with differing biological characteristics. ...The American Cancer Society describes the staging of lymphoma as follows: Stage I is lymphoma in a single node or area. Stage II
Non-Hodgkin lymphomas (NHLs) are a heterogeneous group of lymphoid neoplasms with differing biological characteristics. ...The
16,979 results
You have reached the last available page of results. Please see the User Guide for more information.